Context Therapeutics (CNTX) Current Leases (2022 - 2026)

Context Therapeutics has disclosed Current Leases across 5 years of filings, most recently posting $160055.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $160055.0, up 44.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $160055.0 (up 44.07% YoY), and the FY2025 annual result was $112064.0, up 4.42% from the prior year.
• Current Leases came in at $160055.0 for Q1 2026 at Context Therapeutics, up from $112064.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $160055.0 in Q1 2026 to a low of $7967.0 in Q2 2023.
• The 5-year median for Current Leases is $104160.0 (2024), against an average of $91272.2.
• Across the five-year window, Current Leases sank 91.44% in 2023 and soared 44.07% in 2026, its largest moves.
• Context Therapeutics' Current Leases stood at $55078.0 in 2022, then slumped by 85.54% to $7967.0 in 2023, then soared by 1247.01% to $107316.0 in 2024, then advanced by 4.42% to $112064.0 in 2025, then surged by 42.82% to $160055.0 in 2026.
• The last three Current Leases figures came in at $160055.0 (Q1 2026), $112064.0 (Q4 2025), and $118980.0 (Q3 2025), per Business Quant data.